Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,327.90
-40.90 (-1.73%)
Sep 4, 2026, 3:15 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 961.41 billion as of September 4, 2026. Its market cap has decreased by -8.98% in one year.
Market Cap
961.41B
Enterprise Value
1.01T
Revenue
147.38B
Ranking
n/a
PE Ratio
47.10
Stock Price
2,327.90
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 961.41B, an increase of 68.74%. That is a compound annual growth rate of 17.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 961.41B | 6.03% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.46T |
| Zydus Lifesciences | 1.14T |
| Cipla | 1.13T |
| Laurus Labs | 1.01T |
| Aurobindo Pharma | 942.07B |
| Glenmark Pharmaceuticals | 693.93B |
| Alkem Laboratories | 620.90B |
| Ipca Laboratories | 496.27B |